Quick Takeaways
- Dr. Reddy's Laboratories, Inc. filed SCHEDULE 13G for Coya Therapeutics, Inc. Common Stock, $0.0001 par value per share (COYA).
- Disclosed ownership: 9.7%.
- Date of event: 30 Jan 2026.
Dr. Reddy's Laboratories, Inc. - 30 Jan 2026 SCHEDULE 13G Report for Coya Therapeutics, Inc. Common Stock, $0.0001 par value per share (COYA)
- Filing Manager
- Dr. Reddy's Laboratories, Inc.
- Reporting Manager
- Dr. Reddy's Laboratories, Inc.
- Symbol
- COYA
- Shares outstanding
- 23,430,175 shares
- Disclosed Ownership
- 2,272,727 shares
- Ownership
- 9.7%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Mar 2026, 14:52:51 UTC
- Date of event
- 30 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Dr. Reddy's Laboratories, Inc. disclosed 9.7% ownership in Coya Therapeutics, Inc. Common Stock, $0.0001 par value per share (COYA) on 30 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Mar 2026, 14:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories, Inc. | 9.7% | 2,272,727 | 2,272,727 | 0 | /s/ Stephen Peterson | Vice President, Head of Finance NAG | |
| Dr. Reddy's Laboratories SA | 9.7% | 2,272,727 | 2,272,727 | 0 | /s/ Sameer Natu | Senior Director - Finance | |
| Dr. Reddy's Laboratories Limited | 9.7% | 2,272,727 | 2,272,727 | 0 | /s/ K Randhir Singh | Company Secretary and Compliance Officer |